Amexdrug Corporation
AXRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$33.88K
Close$
Share Statistics
| Market cap | $33,882.00 |
|---|---|
| Enterprise Value | $398,898.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | -0.55 |
| Outstanding Shares | 169,409,620 |
Return
| Return on Equity | 2.50% |
|---|---|
| Return on Assets | 1.90% |
| Return on Invested Capital | 6.76% |
Valuation & Multiples
| P/E Ratio | 0.5 |
|---|---|
| PEG | 1.44 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.14 |
| Enterprise Value to EBIT | 2.63 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 1.06 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Amexdrug Corporation
9 employees
CEO: Jack Amin Amexdrug Corporation, founded in 1963 and headquartered in Commerce, California, operates as a pharmaceutical and cosmeceutical enterprise. Primarily, the company, via its subsidiaries, distributes pharmaceutical products. Beyond this co...